OR WAIT null SECS
Deal helps expands software company’s labeling capabilities in clinical trial, med device and pharma spaces
Loftware Inc., a global software company specializing in enterprise labeling and artwork management solutions, has purchased PRISYM ID, a provider of regulated content and label management solutions that focuses on clinical trials, medical device and pharmaceutical labeling. The acquisition further grows Loftware’s enterprise labeling solution offerings for the medical device and pharma industries, while also developing Loftware’s end-to-end cloud-based labeling platform by adding advanced clinical trial labeling and regulated content management services.
The deal expands on Loftware’s long-standing commitment to medical device and pharma customers, and reinforces the company’s ability to meet labeling complexities and changing regulatory demands.
Building on PRISYM ID’s industry focus, Loftware will offer customers new levels of innovation to help enable compliance through accurate, validation-ready labeling solutions and regulated product content, while also growing the Loftware platform and offering more services to these markets. The platform empowers companies to optimize continuity, improve agility and enable traceability, as they’re faced with new and ensuing challenges around today’s complex supply chain, which has put more emphasis on the importance of labeling.